Evidence map›Paper›PMID 40666313›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Artemisinin resistant

Ayalew Jejaw Zeleke, Abebe A Fola, George A Tollefson, Karamako Niaré, Alec Leonetti, Om Taropawala, Jacob Marglous, Rebecca Crudale, Bokretsion G Brhane, Ashenafi Assefa and 5 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ayalew Jejaw ZelekeDepartment of Medical Parasitology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Abebe A FolaDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
George A TollefsonDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Karamako NiaréDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Alec LeonettiDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Om TaropawalaDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Jacob MarglousDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Rebecca CrudaleDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Bokretsion G BrhaneEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Ashenafi AssefaEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Patience KiyukaKenya Medical Research Institute, Center for Geographic Medicine Research Coast, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Jonathan B ParrInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Asrat HailuDepartment of Medical Parasitology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Mulugeta AemeroDepartment of Medical Parasitology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
Jeffrey A BaileyDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.

Funding

Epidemiology and determinants of emerging artemisinin-resistant malaria in EthiopiaR01AI177791 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jonathan Boyd Parr · 2023 to 2026
$3.2M
NIAID NIH HHS R01 AI177791
6 · The paper itself

Abstract

The rise of antimalarial drug-resistant

Indexed as

ArtemisininEthiopiakelch13MalariaPlasmodium falciparumResistance

Identifiers

PMID40666313
PMCPMC12262759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.